Research study Program year 2025 Source: CMS Open Payments

A Phase II, Open Label, Randomized, Two-Arm Study to Investigate the E

Research payments

$9,000,813

879 payments

Through program year 2025, $9,000,813 in research payments was reported against A Phase II, Open Label, Randomized, Two-Arm Study to Investigate the E, across 879 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$177,131	32
2024	Research	$75,831	14
2023	Research	$558,085	39
2022	Research	$565,244	163
2021	Research	$1,059,581	207
2020	Research	$1,255,510	171
2019	Research	$5,309,432	253

Breakdown

Who paid Research payments · program years 2019–2025

GlaxoSmithKline, LLC. $9,000,813 879 payments

Who received the money Research payments · program years 2019–2025

University Of Washington Organisation paid for research $852,248 67 payments
Trustees Of The University Of Pennsylvania Organisation paid for research $580,028 23 payments
University of Maryland Baltimore Organisation paid for research $527,536 69 payments
Kumc Research Institute INC Organisation paid for research $527,190 53 payments
University Of Utah Organisation paid for research $451,850 61 payments
Trustees of the University of Organisation paid for research $443,372 3 payments
The University Of Texas Organisation paid for research $371,896 16 payments
Indiana University Organisation paid for research $324,689 53 payments
University Of Utah Huntsman Cancer Organisation paid for research $323,734 3 payments
Board Of Regents Of The University Of Wisconsin System Organisation paid for research $277,813 23 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.